IDWeek 2021: Clinical Impact of New Data*

Download All
September 29 - October 3, 2021; Virtual
Apply new and emerging management options for C difficile presented at IDWeek 2021, featuring expert faculty commentaries.
person default
Teena Chopra, MD, MPH
Kevin Garey, PharmD, MS

IDWeek 2021: Clinical Impact of New Data on C difficile

Studies at IDWeek 2021 show that investigational microbiome-directed therapies are efficacious and positively impact quality of life for patients with recurrent C difficile infection. Here is why I am looking forward to using these therapies in my practice.

person default Teena Chopra, MD, MPH Released: December 23, 2021

Here’s how treatment guidelines are changing prescribing patterns in a way that will hopefully improve patient outcomes and decrease patient burden.

Kevin Garey, PharmD, MS Released: December 17, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings